https://www.live-feeds.com/feed/focus-success-after-a-century-of-failures-inside-moderna-and-merck-s-cancer-vaccine-breakthroughContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/focus-success-after-a-century-of-failures-inside-moderna-and-merck-s-cancer-vaccine-breakthroughhttps://www.live-feeds.com/feed/focus-success-after-a-century-of-failures-inside-moderna-and-merck-s-cancer-vaccine-breakthrough#u51788Sat, 29 Aug 2026 13:05:48 +0000A personalized mRNA cancer vaccine developed by Moderna and Merck has achieved success in late-stage trials for melanoma. The treatment aims to prevent the cancer from returning after initial intervention. This development marks a significant milestone in oncology, following a century of unsuccessful attempts to create an effective cancer vaccine. While the trial results are positive, some analysts suggest that public enthusiasm for the technology may be outpacing the actual mathematical data.Why it mattersMost cancer vaccines historically failed to produce consistent results over a hundred-ye